CEO describes CETSA

Friday May 4, 2018

Click here to watch Michael Dabrowski, CEO of Pelago Bioscience describe the Cellular Thermal Shift Assay and the benefits the method brings to drug discovery.

​Click here for a second video on how the Cellular Thermal Shift Assay has helped in the identification of androgen receptor antagonists.

Review Article on CETSA®